(Q34384397)

1 August 2017

1 reference

title

Chemotherapy in stage I+II non-small cell lung cancer (English)

1 reference

1 August 2017

1 reference

Ukena D

1

1 reference

1 August 2017

1 September 2001

1 reference

1 August 2017

1 reference

1 August 2017

33 Suppl 1

1 reference

1 August 2017

S25-8

1 reference

Revisions in the International System for Staging Lung Cancer

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900299-9

7 January 2021

Cancer recurrence after resection: T1 N0 non-small cell lung cancer. Lung Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900299-9

7 January 2021

Adjuvant and neoadjuvant chemotherapy for non-small cell lung cancer: a time for reassessment?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900299-9

7 January 2021

Postoperative adjuvant therapy for patients with resected non-small cell lung cancer: still controversial after all these years

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900299-9

7 January 2021

Is there a role for adjuvant therapy for resected non-small cell lung cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900299-9

7 January 2021

The role of induction therapy in the management of resectable non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900299-9

7 January 2021

Induction chemotherapy before surgery for early-stage lung cancer: A novel approach

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900299-9

7 January 2021

Pre-operative chemotherapy in early stage resectable non-small-cell lung cancer: a randomized feasibility study justifying a multicentre phase III trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900299-9

7 January 2021

10.1016/S0169-5002(01)00299-9

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11576704